Matches in SemOpenAlex for { <https://semopenalex.org/work/W1968072018> ?p ?o ?g. }
- W1968072018 endingPage "20" @default.
- W1968072018 startingPage "11" @default.
- W1968072018 abstract "Among the new therapeutic options for type 2 diabetes care, the incretin-based treatments are considered particularly promising. Two classes of drugs have been developed, GLP-1 receptor agonists and DPP-IV inhibitors, that respectively mimic or prolong the action of the human GLP-1, key-hormone in the glucose homeostasis maintenance.Liraglutide is a GLP-1 analogue recently approved by the European Medicine Agency (EMEA). Efficacy and safety of liraglutide have been tested—in monotherapy and in combination with one or two other antidiabetic treatments—within a comprehensive program of six phase 3 randomized trials (LEAD 1–6), plus three extension phases and several meta-analyses. In the different LEAD studies, the maxi- mum dose of 1.8 mg/day of liraglutide produced after 26 weeks a decrease in HbA1c levels of 1.0%–1.5%, a reduction in fasting blood glucose by about 30 mg/dl, a decrease in body weight of 1–3 Kg, low rates of hypoglycemia, and additional benefits on cardiovascular risk factors. Transient nausea was the most common side effects. Patients treated with liraglutide 1.8 mg had a likelihood from 2 to 11 times greater to achieve one of the two clinically relevant composite endpoints examined (HbA1c < 7%/SBP < 130 mmHg/no weight gain or HbA1c < 7%/no weight gain/no hypoglycemia) as compared with any other placebo/active drugs. Incretin-based therapy has been currently approved for use as add-on therapy in T2DM patients not adequately controlled on maximum doses of metformin, sulfonylureas, TZDs, or their combination. However, if data on long-term efficacy and safety of these drugs will be confirmed, GLP-1 receptor agonists and especially liraglutide could represent an early strategy to delay disease progression and reduce the burden of diabetes and its complications." @default.
- W1968072018 created "2016-06-24" @default.
- W1968072018 creator A5010127891 @default.
- W1968072018 creator A5039243906 @default.
- W1968072018 date "2010-01-01" @default.
- W1968072018 modified "2023-09-26" @default.
- W1968072018 title "Liraglutide: A Review of its Use in the Treatment of Diabetes Mellitus" @default.
- W1968072018 cites W1491092293 @default.
- W1968072018 cites W1518639300 @default.
- W1968072018 cites W1968315455 @default.
- W1968072018 cites W1973901069 @default.
- W1968072018 cites W1975756049 @default.
- W1968072018 cites W1977226383 @default.
- W1968072018 cites W1982615647 @default.
- W1968072018 cites W1983000201 @default.
- W1968072018 cites W1983084864 @default.
- W1968072018 cites W2004977380 @default.
- W1968072018 cites W2013851956 @default.
- W1968072018 cites W2019442960 @default.
- W1968072018 cites W2019566854 @default.
- W1968072018 cites W2027004329 @default.
- W1968072018 cites W2032322539 @default.
- W1968072018 cites W2037791305 @default.
- W1968072018 cites W2043092889 @default.
- W1968072018 cites W2045923887 @default.
- W1968072018 cites W2046645679 @default.
- W1968072018 cites W2063693981 @default.
- W1968072018 cites W2071835038 @default.
- W1968072018 cites W2078128383 @default.
- W1968072018 cites W2081276121 @default.
- W1968072018 cites W2084142744 @default.
- W1968072018 cites W2089304685 @default.
- W1968072018 cites W2098459806 @default.
- W1968072018 cites W2103525547 @default.
- W1968072018 cites W2104818363 @default.
- W1968072018 cites W2106774879 @default.
- W1968072018 cites W2110725041 @default.
- W1968072018 cites W2113094401 @default.
- W1968072018 cites W2118762421 @default.
- W1968072018 cites W2124016563 @default.
- W1968072018 cites W2125053565 @default.
- W1968072018 cites W2127409471 @default.
- W1968072018 cites W2129730863 @default.
- W1968072018 cites W2131094252 @default.
- W1968072018 cites W2132105666 @default.
- W1968072018 cites W2132600402 @default.
- W1968072018 cites W2134141467 @default.
- W1968072018 cites W2137352234 @default.
- W1968072018 cites W2137808916 @default.
- W1968072018 cites W2138290933 @default.
- W1968072018 cites W2139611060 @default.
- W1968072018 cites W2141915016 @default.
- W1968072018 cites W2146602330 @default.
- W1968072018 cites W2146901298 @default.
- W1968072018 cites W2149762820 @default.
- W1968072018 cites W2150913805 @default.
- W1968072018 cites W2152969995 @default.
- W1968072018 cites W2153449155 @default.
- W1968072018 cites W2154595662 @default.
- W1968072018 cites W2156888511 @default.
- W1968072018 cites W2159205789 @default.
- W1968072018 cites W2160001758 @default.
- W1968072018 cites W2167170136 @default.
- W1968072018 cites W2169562373 @default.
- W1968072018 cites W2169849811 @default.
- W1968072018 cites W2170606300 @default.
- W1968072018 cites W2171294019 @default.
- W1968072018 cites W2172204314 @default.
- W1968072018 cites W2207468142 @default.
- W1968072018 cites W2274300369 @default.
- W1968072018 cites W2312161180 @default.
- W1968072018 cites W2509949587 @default.
- W1968072018 cites W2602379183 @default.
- W1968072018 cites W2780952207 @default.
- W1968072018 cites W2785608432 @default.
- W1968072018 cites W3001949083 @default.
- W1968072018 doi "https://doi.org/10.4137/cmrvh.s1652" @default.
- W1968072018 hasPublicationYear "2010" @default.
- W1968072018 type Work @default.
- W1968072018 sameAs 1968072018 @default.
- W1968072018 citedByCount "0" @default.
- W1968072018 crossrefType "journal-article" @default.
- W1968072018 hasAuthorship W1968072018A5010127891 @default.
- W1968072018 hasAuthorship W1968072018A5039243906 @default.
- W1968072018 hasConcept C126322002 @default.
- W1968072018 hasConcept C134018914 @default.
- W1968072018 hasConcept C142724271 @default.
- W1968072018 hasConcept C204787440 @default.
- W1968072018 hasConcept C27081682 @default.
- W1968072018 hasConcept C2776999253 @default.
- W1968072018 hasConcept C2777180221 @default.
- W1968072018 hasConcept C2777391703 @default.
- W1968072018 hasConcept C2778881409 @default.
- W1968072018 hasConcept C2779284873 @default.
- W1968072018 hasConcept C2780282729 @default.
- W1968072018 hasConcept C2780323712 @default.
- W1968072018 hasConcept C2780580376 @default.
- W1968072018 hasConcept C2780668416 @default.